Ridgeline Discovery is looking for a Senior / Principal Scientist, Mass Spectrometry Proteomics .
Ridgeline Discovery, a Versant Ventures Discovery Engine, creates and operates Versant-financed innovative biotech companies in partnership with entrepreneurs, industry, and leading academics across Europe.
In recent years, Ridgeline has assembled an international team of >
50 highly experienced drug discovery professionals and built and operated several new successful companies, including Black Diamond Therapeutics (NASDAQ : BDTX), Bright Peak Therapeutics and Monte Rosa Therapeutics (NASDAQ : GLUE).
Ridgeline is currently expanding its capabilities in Basel to support further company creation efforts in small molecules, biologics, and gene / cell therapy with focus on oncology and immunology.
We are looking for a highly motivated Scientist with strong experience in mass spectrometry-based proteomics for supporting innovative drug discovery.
The candidate will be responsible for independently conducting his / her own proteomics experiments from sample preparation, LC-MS / MS, to data analysis, interpretation, and presentation of the results.
We are looking for a candidate with excellent technical and organizational skills, and a strong collaborative spirit.
You will further strengthen our team by contributing to the development of new biotech companies. You will help increase the biological understanding of programs as well as developing novel analytical assays to help moving our companies forward.
Your role will be comprised of :
To apply, please send us the application form together with your CV and Cover Lett er .